Home LiteratureArticle Details
PMID: 19120293 Published · ppublish English Evaluation Study Journal Article Multicenter Study Review

Update on worldwide efforts to prevent type 1 diabetes.

Annals of the New York Academy of Sciences ·Vol. 1150 ·2008-12-00 ·Pages 190-6

Skyler JS, Type 1 Diabetes TrialNet Study Group

Abstract

This paper reviews worldwide efforts to interdict the type 1 diabetes (T1D) disease process, during the stage of evolution of the disease prior to the time of disease onset. The goal of intervention before disease onset is to arrest immune destruction and thus prevent or delay clinical disease. In this regard, there have been several large-scale multicenter randomized controlled clinical trials designed to prevent T1D. These have tested nicotinamide, parenteral insulin, oral insulin, nasal insulin, and the elimination of cow's milk from infant feeding.

MeSH Terms
Diabetes Mellitus, Type 1/epidemiology,mortality,prevention & control Global Health Humans Models, Biological Niacinamide/therapeutic use Randomized Controlled Trials as Topic Survival Analysis
Chemicals
Niacinamide
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Skyler Jay S
Diabetes Research Institute, Miami, Florida 33101-6960, USA. jskyler@miami.edu
Type 1 Diabetes TrialNet Study Group
References (7)
7 references, click to expand
  1. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
    Diabetes Care. 2005 May;28(5):1068-76 PMID: 15855569
  2. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
    Lancet. 2004 Mar 20;363(9413):925-31 PMID: 15043959
  3. Effects of insulin in relatives of patients with type 1 diabetes mellitus.
    N Engl J Med. 2002 May 30;346(22):1685-91 PMID: 12037147
  4. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
    N Engl J Med. 2005 Jun 23;352(25):2598-608 PMID: 15972866
  5. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
    Diabetologia. 2002 Feb;45(2):217-23 PMID: 11935153
  6. Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR).
    Pediatr Diabetes. 2007 Jun;8(3):117-37 PMID: 17550422
  7. Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).
    Diabetologia. 2003 Mar;46(3):339-46 PMID: 12687331
Article Info
Journal
Annals of the New York Academy of Sciences
Abbr.
Ann N Y Acad Sci
ISSN
1749-6632
Published
2008-12-00
Pages
190-6
Language
English
Region
United States
NLM ID
7506858
PMCID
PMC2928677
Subset
IM
Grants
NIDDK NIH HHS · U01 DK061041 · United States
NIDDK NIH HHS · U01 DK061041-06 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com